Pier Capital’s AdaptHealth AHCO Stock Holding History

Pier Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-174,964	Closed	-$2.8M	–	109
2020 Q1	$2.8M	Buy	+174,964	New	+$2.47M	0.62%	85

Other funds holding AHCO

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pier Capital's AHCO Position: Q2 2020 in Review

Pier Capital sold out of AdaptHealth (AHCO) in Q2 2020, closing a stake of 174,964 shares — an estimated $2.8M sold.

Pier Capital first reported a position in AHCO in Q1 2020 and held it in 1 quarter. The position peaked at $2.8M in Q1 2020. 53 funds tracked by Wall St. Rank hold AHCO as of Q2 2020.

Pier Capital reported no remaining AdaptHealth position as of Q2 2020 after selling out during the quarter.
Pier Capital sold 174,964 AdaptHealth shares in Q2 2020, an estimated $2.8M.
Pier Capital first reported a position in AdaptHealth in Q1 2020 and held it in 1 quarter.
Pier Capital's AdaptHealth position peaked at $2.8M in Q1 2020.
53 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2020.

Based on Pier Capital's 13F filing for Q2 2020, filed 13 Aug 2020.